Tango Therapeutics (TNGX) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Tango Therapeutics (TNGX) over the last 4 years, with Sep 2025 value amounting to -$19.2 million.
- Tango Therapeutics' Other Gross PP&E Adjustments rose 20.42% to -$19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.5 million, marking a year-over-year increase of 16.82%. This contributed to the annual value of -$23.0 million for FY2024, which is 16.66% up from last year.
- As of Q3 2025, Tango Therapeutics' Other Gross PP&E Adjustments stood at -$19.2 million, which was up 4.88% from -$20.2 million recorded in Q2 2025.
- Tango Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $11.0 million during Q2 2022, with a 5-year trough of -$33.3 million in Q3 2022.
- For the 3-year period, Tango Therapeutics' Other Gross PP&E Adjustments averaged around -$25.2 million, with its median value being -$25.2 million (2024).
- Per our database at Business Quant, Tango Therapeutics' Other Gross PP&E Adjustments skyrocketed by 399.42% in 2021 and then plummeted by 11,492.81% in 2022.
- Over the past 5 years, Tango Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $6.1 million in 2021, then slumped by 633.49% to -$32.3 million in 2022, then climbed by 14.61% to -$27.6 million in 2023, then rose by 16.66% to -$23.0 million in 2024, then climbed by 20.42% to -$19.2 million in 2025.
- Its last three reported values are -$19.2 million in Q3 2025, -$20.2 million for Q2 2025, and -$23.2 million during Q1 2025.